In a move to advance productivity, the healthcare division of Germany’s Merck is realigning its drug discovery and launch strategy. Global healthcare research chief Danny...
08.03.2013
- Merck & Co will bring back one of its veterans to head research and development, replacing retiring Peter Kim, who leaves behind a mixed record over the past decade at the...
15.04.2012
- Merck Serono, the biopharmaceutical division of German drugs and chemicals group Merck KGaA, inaugurated on Sunday a biotech incubator at Inter-Lab, its research and development...
